Analyst Ratings for Axsome Therapeutics (AXSM)
AXSM Rating Summary
AXSM Price Target Summary
- Highest: $162.00 (Ladenburg Thalmann)
- Lowest: $27.00 (Morgan Stanley)
- Average: $79.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$79.38 (+95.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 86%
Avg. $ Target:
$79.38 (+95.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2021 | Morgan Stanley » Updated 5/6/2022 |
Vikram Purohit | Downgrade | Equalweight (Overweight) |
27.00 (N/A) |
51.16 (40.64) |
-20.56% | Details |
| 6/10/2021 | Berenberg | Esther Hong | New Coverage | Buy (N/A) |
112.00 (N/A) |
63.50 (40.64) |
-36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
